How much funding has Cartography Biosciences raised?

Cartography Biosciences has raised $67.0M in total funding, most recently a Series B round.

Who are Cartography Biosciences's investors?

Cartography Biosciences's investors include Pfizer Ventures, Andreessen Horowitz.

When was Cartography Biosciences founded?

Cartography Biosciences was founded in 2020.

Where is Cartography Biosciences headquartered?

Cartography Biosciences is headquartered in South San Francisco, California, United States.

What industry is Cartography Biosciences in?

Cartography Biosciences operates in Artificial Intelligence, Healthcare.

How many employees does Cartography Biosciences have?

Cartography Biosciences has 11-50 employees.

Cartography Biosciences

Building a smarter roadmap for precision therapeutics

South San Francisco, United States · Founded 2020 · $67.0M raised

Artificial Intelligence

Healthcare

Headquarters: South San Francisco, California
Employees: 11–50
Founded: 2020
Website: cartography.bio

Total Funding: $67.0M
Last Round: $67.0M Series BOct 2025
Rounds: 1

About

Cartography Biosciences is a therapeutics company building a differentiated pipeline of antibody-based cancer therapies designed to be more precise than existing treatments. The company uses a comprehensive antigen atlas—built from over 15 million tumor and healthy cells analyzed via single-cell sequencing—combined with antibody engineering and computational biology to identify and validate the safest, most effective oncology targets. Founded by Stanford and UCSF researchers, Cartography's platform bridges cellular genomics and drug discovery to widen the world of treatable cancers.

Summary

Cartography Biosciences is an Artificial Intelligence company based in South San Francisco, United States, founded in 2020. It has raised $67.0M in total across 1 round, most recently a $67.0M Series B round in Oct 2025. Investors include Pfizer Ventures and Andreessen Horowitz.

LinkedIn X (Twitter)